CellBion Revenue

CellBion had revenue of 679.12M KRW in the quarter ending September 30, 2025, a decrease of -42.34%. This brings the company's revenue in the last twelve months to 2.13B, down -2.44% year-over-year. In the year 2024, CellBion had annual revenue of 2.29B with 55.64% growth.

Revenue (ttm)

2.13B

Revenue Growth

-2.44%

P/S Ratio

161.46

Revenue / Employee

n/a

Employees

n/a

Market Cap

343.88B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.29B	818.55M	55.64%
Dec 31, 2023	1.47B	-291.63M	-16.54%
Dec 31, 2022	1.76B	846.00M	92.27%
Dec 31, 2021	916.88M	-443.71M	-32.61%
Dec 31, 2020	1.36B	1.01B	288.80%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
DAE HWA Pharmaceutical	149.47B
ImmuneOncia Therapeutics	715.75M
NOVAREX	385.76B
Vivozon Pharmaceutical	66.40B
Organoidsciences	2.55B
OPTUS Pharmaceutical	87.58B
GREEN CROSS WellBeing	151.06B
High Tech Pharm	75.60B

Revenue Rankings